Global Veterinary Therapeutics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Veterinary Therapeutics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Veterinary Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Anti-inflammatory
  • 1.4.3 Parasiticides
  • 1.4.4 Other
• 1.5 Market by Application
  • 1.5.1 Global Veterinary Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Veterinary Clinics
  • 1.5.4 Drug Stores
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Veterinary Therapeutics Market Perspective (2015-2026)
• 2.2 Global Veterinary Therapeutics Growth Trends by Regions
  • 2.2.1 Veterinary Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Veterinary Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Veterinary Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Veterinary Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Veterinary Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Veterinary Therapeutics Players by Market Size
  • 3.1.1 Global Top Veterinary Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Veterinary Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Veterinary Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Veterinary Therapeutics Market Concentration Ratio
  • 3.2.1 Global Veterinary Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Veterinary Therapeutics Revenue in 2019
• 3.3 Veterinary Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Veterinary Therapeutics Product Solution and Service
• 3.5 Date of Enter into Veterinary Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Veterinary Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Veterinary Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Veterinary Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Veterinary Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Veterinary Therapeutics Market Size (2015-2020)
• 6.2 Veterinary Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Veterinary Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Veterinary Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Veterinary Therapeutics Market Size (2015-2020)
• 7.2 Veterinary Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Veterinary Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Veterinary Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Veterinary Therapeutics Market Size (2015-2020)
• 8.2 Veterinary Therapeutics Key Players in China (2019-2020)
• 8.3 China Veterinary Therapeutics Market Size by Type (2015-2020)
• 8.4 China Veterinary Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Veterinary Therapeutics Market Size (2015-2020)
• 9.2 Veterinary Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Veterinary Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Veterinary Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Veterinary Therapeutics Market Size (2015-2020)
• 10.2 Veterinary Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Veterinary Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Veterinary Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Veterinary Therapeutics Market Size (2015-2020)
• 11.2 Veterinary Therapeutics Key Players in India (2019-2020)
• 11.3 India Veterinary Therapeutics Market Size by Type (2015-2020)
• 11.4 India Veterinary Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Veterinary Therapeutics Market Size (2015-2020)
• 12.2 Veterinary Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Veterinary Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Veterinary Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Bayer AG
  • 13.1.1 Bayer AG Company Details
  • 13.1.2 Bayer AG Business Overview
  • 13.1.3 Bayer AG Veterinary Therapeutics Introduction
  • 13.1.4 Bayer AG Revenue in Veterinary Therapeutics Business (2015-2020))
  • 13.1.5 Bayer AG Recent Development
• 13.2 Boehringer Ingelheim GmbH
  • 13.2.1 Boehringer Ingelheim GmbH Company Details
  • 13.2.2 Boehringer Ingelheim GmbH Business Overview
  • 13.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Introduction
  • 13.2.4 Boehringer Ingelheim GmbH Revenue in Veterinary Therapeutics Business (2015-2020)
  • 13.2.5 Boehringer Ingelheim GmbH Recent Development
• 13.3 Ceva Sante Animale
  • 13.3.1 Ceva Sante Animale Company Details
  • 13.3.2 Ceva Sante Animale Business Overview
  • 13.3.3 Ceva Sante Animale Veterinary Therapeutics Introduction
  • 13.3.4 Ceva Sante Animale Revenue in Veterinary Therapeutics Business (2015-2020)
  • 13.3.5 Ceva Sante Animale Recent Development
• 13.4 Dechra Pharmaceuticals PLC
  • 13.4.1 Dechra Pharmaceuticals PLC Company Details
  • 13.4.2 Dechra Pharmaceuticals PLC Business Overview
  • 13.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Introduction
  • 13.4.4 Dechra Pharmaceuticals PLC Revenue in Veterinary Therapeutics Business (2015-2020)
  • 13.4.5 Dechra Pharmaceuticals PLC Recent Development
• 13.5 Eli Lilly and Company (Elanco Animal Health)
  • 13.5.1 Eli Lilly and Company (Elanco Animal Health) Company Details
  • 13.5.2 Eli Lilly and Company (Elanco Animal Health) Business Overview
  • 13.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Introduction
  • 13.5.4 Eli Lilly and Company (Elanco Animal Health) Revenue in Veterinary Therapeutics Business (2015-2020)
  • 13.5.5 Eli Lilly and Company (Elanco Animal Health) Recent Development
• 13.6 Merck Animal Health
  • 13.6.1 Merck Animal Health Company Details
  • 13.6.2 Merck Animal Health Business Overview
  • 13.6.3 Merck Animal Health Veterinary Therapeutics Introduction
  • 13.6.4 Merck Animal Health Revenue in Veterinary Therapeutics Business (2015-2020)
  • 13.6.5 Merck Animal Health Recent Development
• 13.7 Sanofi (Merial Animal Health)
  • 13.7.1 Sanofi (Merial Animal Health) Company Details
  • 13.7.2 Sanofi (Merial Animal Health) Business Overview
  • 13.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Introduction
  • 13.7.4 Sanofi (Merial Animal Health) Revenue in Veterinary Therapeutics Business (2015-2020)
  • 13.7.5 Sanofi (Merial Animal Health) Recent Development
• 13.8 Virbac
  • 13.8.1 Virbac Company Details
  • 13.8.2 Virbac Business Overview
  • 13.8.3 Virbac Veterinary Therapeutics Introduction
  • 13.8.4 Virbac Revenue in Veterinary Therapeutics Business (2015-2020)
  • 13.8.5 Virbac Recent Development
• 13.9 Vetoquinol S.A.
  • 13.9.1 Vetoquinol S.A. Company Details
  • 13.9.2 Vetoquinol S.A. Business Overview
  • 13.9.3 Vetoquinol S.A. Veterinary Therapeutics Introduction
  • 13.9.4 Vetoquinol S.A. Revenue in Veterinary Therapeutics Business (2015-2020)
  • 13.9.5 Vetoquinol S.A. Recent Development
• 13.10 Zoetis, Inc.
  • 13.10.1 Zoetis, Inc. Company Details
  • 13.10.2 Zoetis, Inc. Business Overview
  • 13.10.3 Zoetis, Inc. Veterinary Therapeutics Introduction
  • 13.10.4 Zoetis, Inc. Revenue in Veterinary Therapeutics Business (2015-2020)
  • 13.10.5 Zoetis, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer